Omada Health CAO exercises options and sells shares

Omada Health, Inc. insider Craig Gracey, Chief Accounting Officer, exercised stock options for 1,042 shares of common stock on August 10, 2026 at an exercise price of $6.57 per share.

Rhea-AI Filing Summary

Omada Health, Inc. insider Craig Gracey, Chief Accounting Officer, exercised stock options for 1,042 shares of common stock on August 10, 2026 at an exercise price of $6.57 per share. On the same date, 1,042 common shares were sold at $25.00 per share pursuant to a Rule 10b5-1 trading plan. Following the option exercise, 32,292 option shares remained outstanding and directly held.

Insider Trade Summary 10b5-1

Exercise and Sale: 1,042 shares ($19K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Gracey Craig

Role Chief Accounting Officer

Sold 1,042 shs ($26K)

Approx. gross sale proceeds $26K

Approx. exercise cost $7K

Approx. pre-tax spread $19K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F1, F2	1,042	$0.00	$0.00
Exercise	Common Stock F1	1,042	$6.57	$7K
Sale	Common Stock F1	1,042	$25.00	$26K

Holdings After Transaction: Stock Option (Right to Buy) — 32,292 contracts (Direct); Common Stock — 15,441 shares (Direct)

Footnotes (2)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. F2. 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Key Figures

Options exercised: 1,042 shares Exercise price: $6.57 per share Shares sold: 1,042 shares +4 more

7 metrics

Options exercised 1,042 shares Stock options for common stock exercised on August 10, 2026

Exercise price $6.57 per share Exercise price of stock option converted into common stock

Shares sold 1,042 shares Common stock sale on August 10, 2026

Sale price $25.00 per share Per-share price for common stock sale

Options remaining 32,292 shares Total shares underlying options directly held after the exercise

Option expiration October 23, 2034 Expiration date of the reported stock option award

10b5-1 plan adoption date March 13, 2026 Date Craig Gracey adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Buy), Vesting Commencement Date, Exercise or conversion of derivative security, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

Vesting Commencement Date financial

"25% of the shares subject to the option vest on the first anniversary"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

Common Stock financial

"underlying_security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) report for Craig Gracey?

Omada Health reported that Chief Accounting Officer Craig Gracey exercised options for 1,042 shares at $6.57 per share and sold 1,042 common shares at $25.00 per share on August 10, 2026.

Was the Omada Health (OMDA) insider trade made under a Rule 10b5-1 plan?

Yes. The transactions were made pursuant to a Rule 10b5-1 trading plan adopted by Craig Gracey on March 13, 2026, indicating the trades were pre-arranged rather than discretionary on the trade date.

What option terms applied to Craig Gracey’s Omada Health (OMDA) stock options?

The exercised stock option had an exercise price of $6.57 per share and an expiration date of October 23, 2034. After the reported exercise, 32,292 option shares remained directly held by Craig Gracey.

At what price did the Omada Health (OMDA) insider sell common stock?

On August 10, 2026, Craig Gracey sold 1,042 shares of Omada Health common stock at a price of $25.00 per share, in a transaction coded as a sale of non-derivative securities.

How many Omada Health (OMDA) options does Craig Gracey hold after this Form 4?

After the reported option exercise, Craig Gracey directly held 32,292 shares subject to stock options. This figure relates specifically to the option award referenced in the filing’s derivative transaction table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2026 - 04:46 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gracey Craig

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/10/2026		M(1)		1,042	A	$6.57	16,483	D
Common Stock	08/10/2026		S(1)		1,042	D	$25	15,441	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$6.57	08/10/2026		M(1)			1,042	(2)	10/23/2034	Common Stock	1,042	$0	32,292	D

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

	/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)